Panacea Index Logo

Command Palette

Search for a command to run...

Can a multimodal mind-body program enhance the treatment effects of physical activity in breast cancer survivors with chronic tumor-associated fatigue? A randomized controlled trial.

Integrative cancer therapies
July 1, 2013
Günther Spahn et al. (8 authors)
Journal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to compare the effects of a multimodal mind-body program (MMMT) versus a walking intervention alone on chronic fatigue symptoms in women with stage I to IIIA breast cancer.

Results Summary

Both interventions reduced fatigue symptoms and improved quality of life and functional well-being, but there was no significant difference between the MMMT and walking groups. The study concluded that the MMMT did not provide additional benefits over walking alone for fatigue reduction.

Population

Women (mean age 56.7 years) with stage I to IIIA breast cancer suffering from chronic fatigue after active tumor treatment.

Effective Dosage

Not specified

Duration

10 weeks

Interactions

None mentioned

Extracted Claims (9)
InterventionDirectionEndpointPopulationDosageImpactClaim #
multimodal mind-body program (MMMT), including moderate physical activity
decrease
fatigue scores
women with stage I to IIIA breast cancer suffering from chronic fatigue after active tumor treatment
-
reduced
#1
walking intervention alone
decrease
fatigue scores
women with stage I to IIIA breast cancer suffering from chronic fatigue after active tumor treatment
-
reduced
#2
multimodal mind-body program (MMMT), including moderate physical activity
no change
fatigue scores
women with stage I to IIIA breast cancer suffering from chronic fatigue after active tumor treatment
Δ = -0.3, confidence interval = -1.6 to 1.0, P = .678
no significant difference
#3
multimodal mind-body program (MMMT), including moderate physical activity
no change
fatigue scores
women with stage I to IIIA breast cancer suffering from chronic fatigue after active tumor treatment
Δ = -0.4, confidence interval = -1.8 to 0.9, P = .510
no significant difference
#4
multimodal mind-body program (MMMT), including moderate physical activity
increase
quality of life (QoL)
women with stage I to IIIA breast cancer suffering from chronic fatigue after active tumor treatment
-
improved
#5
walking intervention alone
increase
quality of life (QoL)
women with stage I to IIIA breast cancer suffering from chronic fatigue after active tumor treatment
-
improved
#6
multimodal mind-body program (MMMT), including moderate physical activity
increase
general functional well-being
women with stage I to IIIA breast cancer suffering from chronic fatigue after active tumor treatment
-
improved
#7
walking intervention alone
increase
general functional well-being
women with stage I to IIIA breast cancer suffering from chronic fatigue after active tumor treatment
-
improved
#8
multimodal mind-body program (MMMT), including moderate physical activity
no change
fatigue symptoms
women with stage I to IIIA breast cancer suffering from chronic fatigue after active tumor treatment
-
no verifiable add-on effect
#9
Abstract

UNLABELLED: Background. Chronic fatigue is one of the most restricting symptoms following primary breast cancer treatment, but clinical studies on symptom management are rare. The objective was to evaluate the impact of a multimodal mind-body program (MMMT), including moderate physical activity as compared with a walking intervention alone, on chronic fatigue symptoms of women with stage I to IIIA breast cancer. PATIENTS AND METHODS: Sixty-four women (mean age = 56.7 years) suffering from chronic fatigue after active tumor treatment were randomly assigned to either an experimental or a control (n = 32 each) intervention (10 weeks). Fatigue, quality of life (QoL), functional well-being, anxiety, and depression were measured with standard questionnaires at baseline, after 10 weeks, and after 3 months. RESULTS: Compared with baseline, both groups had reduced fatigue scores after treatment without any significant difference between groups (posttreatment, Δ = -0.3, confidence interval = -1.6 to 1.0, P = .678; follow-up, Δ = -0.4, confidence interval = -1.8 to 0.9, P = .510). All patients also improved regarding QoL and general functional well-being. CONCLUSION: Since both interventions reduced fatigue symptoms and enhanced QoL to a similar extent, we observed no verifiable add-on effect of the MMMT regarding fatigue symptoms. Considering the higher costs with additional expenditure related to MMMT, home-based walking intervention is recommended.

Medical Subject Headings (MeSH)
AdultAgedBreast NeoplasmsChronic DiseaseCombined Modality TherapyFatigueFemaleHumansMiddle AgedMind-Body TherapiesMotor ActivityQuality of LifeSurvivorsTreatment Outcome
Study Links
Quality Scores
SafetyNot Assessed
Efficacy60/10
Quality75/10
Citation Metrics
Total Citations37
Citations/Year3.1
Relative Citation Ratio1.50
NIH Percentile65%
Research Impact Scores
APT Score0.75
Weight Score1.53
Normalized Score0.59
Related Supplements